Table 6. Patient details for PR or prolonged SD.
| Pt # | Eribulin mesylate dose mg m−2 per cisplatin dose mg m−2 (schedule) | Response | Disease site | Weeks on treatment |
|---|---|---|---|---|
| 1 |
1.0/60 (28d) |
PR |
Pancreatic |
18 (Off for PD) |
| 2 |
1.2/60 (28d) |
PR |
Breast |
24 (Off for PD) |
| 3 |
1.4/60 (21d) |
PR |
Oesophagus |
17 (Off for PD) |
| 4 |
1.2/75 (21d) |
PR |
Bladder |
17 (Off due to surgery) |
| 5 |
1.0/60 (28d) |
SD |
Head/neck |
25 (Off for pt refusal) |
| 6 |
1.2/60 (28d) |
SD |
Appendix |
30 (Off for MD discretion) |
| 7 |
1.2/60 (28d) |
SD |
Head/neck |
16 (Off for pt refusal) |
| 8 |
1.2/60 (28d) |
SD |
Ovary |
32 (Off for PD) |
| 9 |
1.2/60 (28d) |
SD |
Lung |
21 (Off for MD discretion) |
| 10 |
1.2/60 (28d) |
SD |
Lung |
11 (Off for Pt refusal) |
| 11 |
1.4/60 (28d) |
SD |
Lung |
31 (Off for PD) |
| 12 |
1.4/60 (21d) |
SD |
Pancreas |
18 (Off for PD) |
| 13 |
1.4/60 (21d) |
SD |
Lung |
23 (Off for Tox) |
| 14 |
1.4/60 (21d) |
SD |
Head/neck |
27 (Off for PD) |
| 15 |
1.2/75 (21d) |
SD |
Head/neck |
28 (Off for PD) |
| 16 |
1.2/75 (21d) |
SD |
Lung |
24 (Off for MD discretion) |
| 17 | 1.2/75 (21d) | SD | Head/neck | 21 (off for Pt refusal) |
Abbreviations: PD=progressive disease; PR=partial response; SD=stable disease; prolonged SD=prolonged stable disease (stable disease for six cycles or more or stable disease and off treatment due to patient refusal or MD discretion).